MAYA MARTINEZ-DAVIS was appointed global head of the oncology franchise of Merck KGaA. She will be based in Billerica, Mass., and will report to Rehan Verjee, chief marketing and strategy officer of the healthcare business sector. Martinez-Davis was a senior executive with Pfizer for more than a decade. Prior to her tenure with Pfizer, she...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
